Drug: irinotecan hcl Quarter: 2016Q3
Total Records: 86 Number of Pages: 5
| DRUGNAME | PT | EventCount |
|---|---|---|
| IRINOTECAN HCL | Fatigue | 2 |
| IRINOTECAN HCL | Gait disturbance | 2 |
| IRINOTECAN HCL | General physical health deterioration | 2 |
| IRINOTECAN HCL | Hypertension | 2 |
| IRINOTECAN HCL | Infusion related reaction | 2 |
| IRINOTECAN HCL | Larynx irritation | 2 |
| IRINOTECAN HCL | Lower respiratory tract infection | 2 |
| IRINOTECAN HCL | Mouth ulceration | 2 |
| IRINOTECAN HCL | Nausea | 2 |
| IRINOTECAN HCL | Platelet count decreased | 2 |
| IRINOTECAN HCL | Vestibular disorder | 2 |
| IRINOTECAN HCL | White blood cell count decreased | 2 |
| IRINOTECAN HCL | Abdominal pain upper | 1 |
| IRINOTECAN HCL | Anaphylactic reaction | 1 |
| IRINOTECAN HCL | Aphonia | 1 |
| IRINOTECAN HCL | Arteriosclerosis coronary artery | 1 |
| IRINOTECAN HCL | Arthralgia | 1 |
| IRINOTECAN HCL | Arthropathy | 1 |
| IRINOTECAN HCL | Bacteraemia | 1 |
| IRINOTECAN HCL | Change of bowel habit | 1 |
Total Records: 86 Number of Pages: 5